Evidence map›Paper›PMID 25333917›Full record

ArticleACS chemical biology2014

Reconstruction of cladoniamide biosynthesis reveals nonenzymatic routes to bisindole diversity.

Yi-Ling Du, David E Williams, Brian O Patrick, Raymond J Andersen, Katherine S Ryan

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Yeast homologous recombination-based promoter engineering for the activation of silent natural product biosynthetic gene clusters.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yi-Ling DuDepartment of Chemistry and ‡Department of Earth, Ocean and Atmospheric Sciences, University of British Columbia , Vancouver, Canada.
David E Williams
Brian O Patrick
Raymond J Andersen
Katherine S Ryan
University of British Columbia · CA

Funding

CIHR 130486-1CIHR 136653-1
6 · The paper itself

Abstract

Indolotryptolines are bisindole natural products isolated from microbial and eDNA sources. Here, we report the sequence of transformations that convert an indolocarbazole to the indolotryptoline cladoniamide through reconstruction of the four-enzyme cascade in E. coli. This cascade involves, first, conversion of an indolocarbozole to a C4c-C7a cis diol by ClaX1; second, N-methylation by ClaM1; third, rearrangement to the indolotryptoline scaffold by ClaX2; and fourth, installation of an O-methyl group by ClaM3. We furthermore elucidate the origins of minor cladoniamides D-G as the products of nonenzymatic, base-catalyzed opening of the succinimide ring of cladonimiades A-B. Overall, this work reveals the precarious pathway indolocarbazole-derived metabolites must traverse as they are converted into indolotryptoline products and highlights the importance of nonenzymatic chemistry in generating bisindole diversity.

Indexed as

Genes, BacterialGenome, BacterialBiological ProductsBiotransformationEscherichia coliGene ExpressionIndole AlkaloidsIndolesMolecular StructureMultigene FamilyPiperidinesSuccinimidesBiological Productscladoniamide GIndole AlkaloidsIndolesPiperidinesSuccinimides

Identifiers

PMID25333917
PMCPMC4613803
OpenAlexW2110518176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.